Le Lézard
Classified in: Science and technology
Subjects: Product/Service, Award

Clarify Health Named Best Predictive Analytics Solution by MedTech Breakthrough Awards


Clarify Health, an award-winning healthcare data analytics platform company, is pleased to announce it has received the "Best Predictive Analytics Solution" award from MedTech Breakthrough Awards. The award recognizes Clarify for combining predictive claims-based data analytics with behavioral economics, enabling the identification of high-performing providers, and driving cost-effective referrals to specialists.

These analytical methodologies are powered by the Clarify Atlas Platform®, which maps 300M+ patient journeys to deliver 18B+ AI-powered predictions and surfaces actionable insights into performance, trends, and benchmarks with unprecedented clarity, precision, and speed.

"We help healthcare organizations across the country identify and act on precise insights to optimize care quality and efficiency," commented Clarify CEO Terry Boch. "Our customers, which include some of the most innovative health plans, leverage transparent provider performance insights and flexible provider engagement programs to build trust and behavior change. This award reaffirms our position at the forefront of transformative healthcare analytics."

Clarify was selected from 4,500 nominations. This is Clarify's second MedTech Breakthrough Award. Two years ago, the company was awarded the "Best Overall Healthcare Data Analytics Platform." Earlier this year, KLAS Research ranked Clarify #1 in Data Analytics Platforms (Payers) in its 2024 Best in KLAS Awards ? Software and Services, and most recently, Clarify was named among the world's best in data analytics in Newsweek and Statista's inaugural ranking of the World's Best Digital Health Companies. Clarify has also received several recognitions from industry analysts and market intelligence platforms for its high customer satisfaction and innovation in healthcare analytics.

About Clarify Health

Clarify Health is an enterprise data and analytics platform company that enables providers, payers, and other healthcare organizations to improve healthcare access, affordability, and outcomes. Clarify translates one of the largest healthcare datasets into actionable insights to incentivize and engage providers, optimize their performance, and contain cost. Clarify's solutions are built on the Clarify Atlas Platform which maps 300M+ patient journeys to deliver 18B+ AI-powered predictions and surface insights with speed and precision. These insights illuminate opportunities to drive growth, optimize provider networks, guide better healthcare pathways, and maximize value-based care performance.

About MedTech Breakthrough

MedTech Breakthrough is an independent market intelligence organization that recognizes the top breakthrough companies, technologies, and products in the global health and medical technology market.


These press releases may also interest you

at 06:23
IDTechEx, a trusted provider of independent market intelligence, have released a new market report, "Thermal Interface Materials 2024-2034: Technologies, Markets, and Forecasts". The report forecasts the global TIM market size will reach around...

at 06:16
Aramco, one of the world's leading integrated energy and chemicals companies, has signed an agreement with Pasqal, a global leader in neutral atom quantum computing, to install the first quantum computer in the Kingdom of Saudi Arabia. The agreement...

at 06:09
Béné Tipping, the premier digital tipping platform for hospitality service providers, announced the launch of a first-of-its-kind cashless tipping platform that allows employers and customers to team up on tipping. This unique feature fixes the...

at 06:07
Seed Health will present new clinical data on its flagship innovation, DS-01® Daily Synbiotic, a 24-strain probiotic and prebiotic, at the upcoming 2024 Digestive Disease Week® (DDW) meeting. The presentations will highlight the results from two...

at 06:05
Arrowhead Pharmaceuticals, Inc. today announced that new interim clinical data on ARO-RAGE, an investigational RNAi-based medicine for the treatment of inflammatory lung diseases, such as asthma, were presented at the American Thoracic Society (ATS)...

at 06:01
ADAMA Ltd. (SZSE 000553), a leading global crop protection company, today published its 2023 Environmental, Social and Governance (ESG) Report. The report details the company's commitment to transparency and incorporating several key standards from...



News published on and distributed by: